Hologic, Inc. $HOLX Shares Sold by TD Asset Management Inc

TD Asset Management Inc lowered its position in shares of Hologic, Inc. (NASDAQ:HOLX) by 3.0% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 1,484,641 shares of the medical equipment provider’s stock after selling 45,676 shares during the quarter. TD Asset Management Inc’s holdings in Hologic were worth $100,198,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the company. The Manufacturers Life Insurance Company increased its holdings in shares of Hologic by 294.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 11,022,455 shares of the medical equipment provider’s stock valued at $718,223,000 after acquiring an additional 8,227,318 shares during the last quarter. Invesco Ltd. boosted its holdings in Hologic by 72.5% in the second quarter. Invesco Ltd. now owns 8,340,785 shares of the medical equipment provider’s stock worth $543,486,000 after purchasing an additional 3,505,828 shares during the period. Geode Capital Management LLC increased its stake in Hologic by 1.7% during the second quarter. Geode Capital Management LLC now owns 5,828,325 shares of the medical equipment provider’s stock valued at $378,209,000 after purchasing an additional 97,142 shares during the last quarter. Black Creek Investment Management Inc. increased its stake in Hologic by 26.1% during the second quarter. Black Creek Investment Management Inc. now owns 4,027,829 shares of the medical equipment provider’s stock valued at $262,453,000 after purchasing an additional 832,444 shares during the last quarter. Finally, Bank of America Corp DE raised its holdings in shares of Hologic by 2.2% during the second quarter. Bank of America Corp DE now owns 3,090,306 shares of the medical equipment provider’s stock worth $201,364,000 after purchasing an additional 66,453 shares during the period. Institutional investors own 94.73% of the company’s stock.

Hologic Trading Down 0.0%

NASDAQ:HOLX opened at $75.34 on Thursday. The stock has a market cap of $16.82 billion, a price-to-earnings ratio of 31.39, a PEG ratio of 2.25 and a beta of 0.72. The company has a debt-to-equity ratio of 0.48, a quick ratio of 3.32 and a current ratio of 4.04. Hologic, Inc. has a 1 year low of $51.90 and a 1 year high of $75.49. The business has a fifty day moving average of $74.94 and a 200-day moving average of $72.04.

Hologic (NASDAQ:HOLX) last posted its quarterly earnings data on Thursday, January 29th. The medical equipment provider reported $1.04 earnings per share for the quarter, missing the consensus estimate of $1.09 by ($0.05). The company had revenue of $1.05 billion during the quarter, compared to analyst estimates of $1.07 billion. Hologic had a return on equity of 19.58% and a net margin of 13.18%.The business’s revenue for the quarter was up 2.5% compared to the same quarter last year. During the same period in the previous year, the company earned $0.87 EPS. Equities analysts predict that Hologic, Inc. will post 4.28 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of Hologic in a research report on Tuesday, November 4th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Hologic in a report on Wednesday, January 28th. Evercore downgraded Hologic from an “outperform” rating to an “in-line” rating and cut their price target for the stock from $79.00 to $78.00 in a report on Monday, January 5th. BNP Paribas Exane lowered Hologic from a “strong-buy” rating to a “hold” rating and set a $79.00 price objective for the company. in a research report on Friday, November 21st. Finally, Argus lowered Hologic from a “buy” rating to a “hold” rating in a research report on Monday, January 12th. Two research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $78.42.

Hologic Company Profile

Hologic, Inc (NASDAQ: HOLX) is a global medical technology company specializing in women’s health. Headquartered in Marlborough, Massachusetts, the company develops and manufactures diagnostic products, imaging systems and surgical solutions designed to detect, diagnose and treat diseases with a primary focus on breast and skeletal health, gynecological conditions and molecular diagnostics. Its product portfolio includes digital mammography systems, 3D mammography solutions, bone densitometry equipment and molecular assays for infectious disease and oncology applications.

Since its founding in 1985, Hologic has grown through both internal innovation and strategic acquisitions.